ReviewLife (Basel, Switzerland)2021

Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence.

Brett D M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.